Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling

Cardiovascular Research

Volumn 70, Issue 2, 2006, Pages 315-324

  Zatta, Amanda J ^a   Kin, Hajime ^a   Lee, George ^a   Wang, Ningping ^a   Jiang, Rong ^a   Lust, Robert ^b   Reeves, James G ^a   Mykytenko, James ^a   Guyton, Robert A ^a   Zhao, Zhi Qing ^a   Vinten Johansen, Jakob ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c NONE

Author keywords

Mitochondria; Myocardial infarction; Postconditioning; Protein kinase C; Protein phosphorylation; Reperfusion injury

Indexed keywords

CHELERYTHRINE; PEPTIDE KIE1 1; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; ROTTLERIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEART RATE; HEMODYNAMICS; LEFT CORONARY ARTERY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ACETOPHENONES; ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; BENZOPYRANS; BLOTTING, WESTERN; CYTOSOL; MALE; MITOCHONDRIA, HEART; MODELS, ANIMAL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; NECROSIS; PEPTIDES; PHENANTHRIDINES; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; PROTEIN KINASE C-EPSILON; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 33646016843     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.11.030     Document Type: Article

References (53)

1. Vinten-Johansen J., Zhao Z.Q., Zatta A.J., Kin H., Halkos M.E., and Kerendi F. Postconditioning a new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol 100 (2005) 295-310
2. Tsang A., Hausenloy D.J., Mocanu M.M., and Yellon D.M. Postconditioning: a form of "Modified Reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-akt pathway. Circ Res 95 (2004) 230-232
3. Yang X.M., Proctor J.B., Cui L., Krieg T., Downey J.M., and Cohen M.V. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 44 (2004) 1103-1110
4. Darling C.E., Jiang R., Maynard M., Whittaker P., Vinten-Johansen J., and Przyklenk K. 'Postconditioning' via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK 1/2. Am J Physiol Heart Circ Physiol 289 (2005) H1618-H1626
5. Yang X.M., Philipp S., Downey J.M., and Cohen M.V. Postconditioning protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 100 (2005) 57-63
6. Inagaki K., Hahn H.S., Dorn II G.W., and Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. Circulation 108 (2003) 869-875
7. Inagaki K., Chen L., Ikeno F., Lee F.H., Ki I., Bouley D.M., et al. Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation 108 (2003) 2304-2307
8. Bright R., Raval A.P., Dembner J.M., Perez-Pinzon M.A., Steinberg G.K., Yenari M.A., et al. Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci 24 (2004) 6880-6888
9. Churchill E.N., and Szweda L.I. Translocation of delta PKC to mitochondria during cardiac reperfusion enhances superoxide anion production and induces loss in mitochondrial function. Arch Biochem Biophys 439 (2005) 194-199
10. Murriel C.L., Churchill E., Inagaki K., Szweda L.I., and Mochly-Rosen D. Protein kinase C delta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J Biol Chem 279 (2004) 47985-47991
11. Liu G.S., Cohen M.V., Mochly-Rosen D., and Downey J.M. Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 31 (1999) 1937-1948
12. Ludwig L.M., Weihrauch D., Kersten J.R., Pagel P.S., and Warltier D.C. Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species. Anesthesiology 100 (2004) 532-539
13. Novalija E., Kevin L.G., Camara A.K.S., Bosnjak K.J., Kampine J.P., and Stowe D.F. Reactive oxygen species precede the epsilon isoform of protein kinase C in the anesthetic preconditioning signaling cascade. Anesthesiology 99 (2003) 421-428
14. Ping P., Zhang J., Qiu Y., Tang X.L., Manchikalapudi S., Cao X., et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81 (1997) 404-414
15. Qiu Y., Ping P., Tang X.L., Manchikalapudi S., Rizvi A., Zhang J., et al. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved. J Clin Invest 101 (1998) 2182-2198
16. Toma O., Weber N.C., Wolter J.I., Obal D., Preckel B., and Schlack W. Desflurane preconditioning induces time-dependent activation of protein kinase C epsilon and extracellular signal-regulated kinase 1 and 2 in the rat heart in vivo. Anesthesiology 101 (2004) 1372-1380
17. Chiari P.C., Bienengraeber M.W., Pagel P.S., Krolikowski J.G., Kersten J.R., and Warltier D.C. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 102 (2005) 102-109
18. Baines C.P., Song C.X., Zheng Y.T., Wang G.W., Zhang J., Wang O.L., et al. Protein kinase C epsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 92 (2003) 873-880
19. Argaud L., Gateau-Roesch O., Raisky O., Loufouat J., Robert D., and Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 111 (2005) 194-197
20. Sayen M.R., Gustafsson A.B., Sussman M.A., Molkentin J.D., and Gottlieb R.A. Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production. Am J Physiol Cell Physiol 284 (2003) C562-C570
21. Kin H., Zatta A.J., Lofye M.T., Amerson B.S., Halkos M.E., Kerendi F., et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 67 (2005) 124-133
22. Herbert J.M., Augereau J.M., Gleye J., and Maffrand J.P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172 (1990) 993-999
23. Zhao T.C., and Kukreja R.C. Protein kinase C-delta mediates adenosine A3 receptor-induced delayed cardioprotection in mouse. Am J Physiol Heart Circ Physiol 285 (2003) H434-H441
24. Liu Y., Cohen M.V., and Downey J.M. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the anti-infarct effect of ischemic preconditioning in rabbit hearts. Cardiovasc Drugs Ther 8 (1994) 881-882
25. Fryer R.M., Hsu A.K., Wang Y., Henry M., Eells J., and Gross G.J. PKC-delta inhibition does not block preconditioning-induced preservation in mitochondrial ATP synthesis and infarct size reduction in rats. Basic Res Cardiol 97 (2002) 47-54
26. Johnson J.A., Gray M.O., Chen C.H., and Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem 271 (1996) 24962-24966
27. Chen L., Wright L.R., Chen C.H., Oliver S.F., Wender P.A., and Mochly-Rosen D. Molecular transporters for peptides: delivery of a cardioprotective epsilon PKC agonist peptide into cells and intact ischemic heart using a transport system, R7. Chem Biol 8 (2001) 1123-1129
28. Murriel C.L., and Mochly-Rosen D. Opposing roles of delta and epsilon PKC in cardiac ischemia and reperfusion: targeting the apoptotic machinery. Arch Biochem Biophys 420 (2003) 246-254
29. Kin H., Zatta A.J., Jiang R., Reeves J.G., Mykytenko J., Sorescu G., et al. Activation of opioid receptors mediates the infarct size reduction by postconditioning. J Mol Cell Cardiol (2005) 38 [abstract]
30. Cross H.R., Murphy E., Bolli R., Ping P., and Steenbergen C. Expression of activated PKC epsilon (PKC epsilon) protects the ischemic heart, without attenuating ischemic H+ production. J Mol Cell Cardiol 34 (2002) 361-367
31. Ping P., Zhang J., Zheng Y.T., Li R.C.X., Guo Y., Bao W., et al. Cardiac targeted transgenesis of active PKC renders the heart resistant to infarction. Circulation 102 (2000) II-24 [abstract]
32. Jin Z.Q., Zhou H.Z., Zhu P., Honbo N., Mochly-Rosen D., Messing R.O., et al. Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKCepsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol 282 (2002) H1970-H1977
33. Saurin A.T., Pennington D.J., Raat N.J.H., Latchman D.S., Owen M.J., and Marber M.S. Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res 55 (2002) 672-680
34. Gray M.O., Zhou H.Z., Schafhalter-Zoppoth I., Zhu P., Mochly-Rosen D., and Messing R.O. Preservation of base-line hemodynamic function and loss of inducible cardioprotection in adult mice lacking protein kinase C epsilon. J Biol Chem 279 (2004) 3596-3604
35. Okada T., Otani H., Wu Y., Uchiyama T., Kyoi S., Hattori R., et al. Integrated pharmacological preconditioning and memory of cardioprotection: role of protein kinase C and phosphatidylinositol 3-kinase. Am J Physiol Heart Circ Physiol 289 (2005) H761-H767
36. Ping P., Takano H., Zhang J., Tang X.L., Qiu Y., Li R.C.X., et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide induced and ischemia-induced preconditioning. Circ Res 84 (1999) 587-604
37. Xu P., Wang J., Kodavatiganti R., Zeng Y., and Kass I.S. Activation of protein kinase C contributes to the isoflurane-induced improvement of functional and metabolic recovery in isolated ischemic rat hearts. Anesth Analg 99 (2004) 993-1000
38. Dorn II G.W., Souroujon M.C., Liron T., Chen C.H., Gray M.O., Zhou H.Z., et al. Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci 96 (1999) 12798-12803
39. Hausenloy D.J., Tsang A., and Yellon D.M. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 15 (2005) 69-75
40. Aizawa K., Turner L.A., Weihrauch D., Bosnjak K.J., and Kwok W.M. Protein kinase C-epsilon primes the cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel to modulation by isoflurane. Anesthesiology 101 (2004) 381-389
41. Obal D., Weber N.C., Zacharowski K., Toma O., Dettwiler S., Wolter J.I., et al. Role of protein kinase C-epsilon (PKCepsilon) in isoflurane-induced cardioprotection. Br J Anaesth 94 (2005) 166-173
42. Zhang J., Bolli R., Lalli J., Tang X.L., Li R.C.X., Zheng Y., et al. Ischemic preconditioning and phorbol ester redistribute protein kinase C epsilon to the nucleus, sarcolemmal membranes, and mitochondria in rabbit myocardium. Circulation 100 (1999) I-325 [abstract]
43. Baines C.P., Zhang J., Wang G.W., Zheng Y.T., Xiu J.X., Cardwell E.M., et al. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res 90 (2002) 390-397
44. 2+ overload. Am J Physiol Heart Circ Physiol 288 (2005) H1900-H1908
45. Costa A.D.T., Garlid K.D., West I.C., Lincoln T.M., Downey J.M., Cohen M.V., et al. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 97 (2005) 329-336
46. Uecker M., da Silva R., Grampp T., Pasch T., Schaub M.C., and Zaugg M. Translocation of protein kinase C isoforms to subcellular targets in ischemic and anesthetic preconditioning. Anesthesiology 99 (2003) 138-147
47. Simonis G., Weinbrenner C., and Strasser R.H. Ischemic preconditioning promotes a transient, but not sustained translocation of protein kinase C and sensitization of adenylyl cyclase. Basic Res Cardiol 98 (2003) 104-113
48. Chen L., Hahn H., Wu G., Chen C.H., Liron T., Schechtman D., et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci 98 (2001) 11114-11119
49. Chou W.H., Choi D.S., Zhang H., Mu D., McMahon T., Kharazia V.N., et al. Neutrophil protein kinase delta as a mediator of stroke-reperfusion injury. J Clin Invest 114 (2004) 49-56
50. Churchill E.N., Murriel C.L., Chen C.H., Mochly-Rosen D., and Szweda L.I. Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation. Circ Res 97 (2005) 78-85
51. Kerendi F., Kin H., Halkos M.E., Jiang R., Zatta A.J., Zhao Z.G., et al. Remote postconditioning: brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors. Basic Res Cardiol 100 (2005) 404-412
52. Halkos M.E., Kerendi F., Corvera J.S., Wang N.P., Kin H., Payne C.S., et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg 78 (2004) 961-969
53. Kin H., Zhao Z.Q., Sun H.Y., Wang N.P., Corvera J.S., Halkos M.E., et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62 (2004) 74-85